| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.3 | 3e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |